Rockville, March 05, 2024 (GLOBE NEWSWIRE) -- The global cardiac pacemaker market, estimated at US$ 3.92 billion in 2024, is projected to reach US$ 6.15 billion by the end of 2034, according to the latest study by Fact.MR.
A pacemaker is a medical device that contracts the heart muscles and controls the heart's electrical conduction system by producing electrical pulses that are delivered via electrodes. The market for cardiac pacemakers is expanding as a result of factors such as rising healthcare costs, the aging population, and the increasing prevalence of atrial fibrillation.
Get Free Sample Copy of This Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=8029
Heightened awareness about interventions needed for cardiac arrhythmias, increasing product approvals by regulatory bodies, and rising confidence about the safety and effectiveness of cardiac pacemakers among patients are factors driving market growth.
| Report Attribute | Details |
| Value Projection (2034) | US$ 6.15 Billion |
| Growth Rate (2024-2034) | 4.6% CAGR |
| No. of pages | 170 Pages |
| No. of Tables | 84 Tables |
| No. of Figures | 112 Figures |
Key Takeaways from Market Study
- In 2024, the global market for cardiac pacemakers is estimated at US$ 3.92 billion.
- Demand for cardiac pacemakers is projected to rise at a CAGR of 4.6% from 2024 to 2034.
- By the end of 2034, the market is forecasted to reach US$ 6.15 billion.
- The market in East Asia is forecasted to expand at a CAGR of 5% through 2034.
- Demand for implantable pacemakers is projected to increase at a CAGR of 4.6% during the forecast period.
- From 2024 to 2034, the market in North America is forecasted to expand at a CAGR of 4.6%.
“Expanding healthcare sector and advancements in technology drive the cardiac pacemaker market. Healthcare providers are focusing on enhancing patient outcomes and addressing the distinctive requirements of the aging population. By combining novel technologies with a dedication to patient safety and tailored treatment, cardiac pacemakers are positioned as essential tools in the continuous fight against cardiovascular illnesses,” says a Fact.MR analyst.
Key Companies Profiled in This Report
- Medtronic PLC
- Biotronik SE & Co. KG
- Boston Scientific Corporation
- Lepu Medical Co. Ltd.
- Abbott Laboratories (ST Jude Medical)
- Osypka Medical
- OSCOR Inc.
- MicroPort Scientific Corporation
- Medico S.R.L.
- Shree Pacetronix Ltd.
Focus on Development of Premium Pacemakers for Personalized Care
The market is expanding primarily due to the rising prevalence of cardiovascular diseases (CVDs), rising management costs for cardiac diseases, pro-business government regulations, and the introduction of more advanced pacemakers with advanced technology, like leadless and MRI-safe models. The growing prevalence of cardiovascular illnesses is one of the main drivers of the market's expansion. One of the main causes of CVD fatalities worldwide is coronary heart disease.
Global companies nowadays are committed to producing premium pacemakers (biventricular pacemakers) that fully satisfy every patient's need and enable personalized care. These recent developments are significantly improving workflow precision and enabling mistake reduction rates, which presents lucrative opportunities for manufacturers.
- In June 2021, India Medtronic Private Limited launched Micra AV, an innovative, self-contained mini pacemaker. Employing a minimally invasive approach, Micra AV offers advanced pacing technology for patients with atrioventricular (AV) block. Notably, it is the first of its kind to sense atrial activity without requiring a lead or any device in the heart's upper chamber.
Get Customization on this Report for Specific Research Solutions:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=8029
More Valuable Insights on Offer
Fact.MR, in its new offering, presents an unbiased analysis of the cardiac pacemaker market for 2018 to 2023 and forecast statistics for 2024 to 2034.
The study divulges essential insights into the market based on product type (implantable pacemakers, external pacemakers), technology (single chamber, dual chamber, biventricular/cardiac resynchronization therapy-pacemakers (CRT-P), and end user (hospitals, ambulatory surgical centers), across six major regions of the world (North America, Latin America, Europe, East Asia, South Asia & Oceania, and MEA).
Explore More Related Studies Published by Fact.MR Research:
Cardiac Prosthetic Devices Market: Global sales of cardiac prosthetic devices are expected to grow at a 7.6% CAGR from 2022 to 2027. The global cardiac prosthetic devices market is expected to be worth US$ 9.5 billion by 2027, up from US$ 6.6 billion in 2022.
Cardiac Marker Analyzer Market: The global cardiac marker analyzer market size is estimated at US$ 883.3 million in 2024 and is projected to increase to US$ 1.38 billion by the end of 2034, expanding at a CAGR of 4.6% over the next ten years (2024–2024).
Cardiac Biomarkers Market: Worldwide demand for cardiac biomarkers is projected to accelerate at a CAGR of 11% and reach a market value of US$ 38 billion by 2033.
About Fact.MR:
Fact.MR is a distinguished market research company renowned for its comprehensive market reports and invaluable business insights. As a prominent player in business intelligence, we deliver deep analysis, uncovering market trends, growth paths, and competitive landscapes. Renowned for its commitment to accuracy and reliability, we empower businesses with crucial data and strategic recommendations, facilitating informed decision-making and enhancing market positioning. With its unwavering dedication to providing reliable market intelligence, FACT.MR continues to assist companies in navigating dynamic market challenges with confidence and achieving long-term success. With a global presence and a team of experienced analysts, FACT.MR ensures its clients receive actionable insights to capitalize on emerging opportunities and stay ahead in the competitive landscape.
Contact:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232 (D)
Sales Team: sales@factmr.com
Follow Us: LinkedIn | Twitter | Blog
